Candel Therapeutics schedules call on prostate cancer trial data

May 4, 2026 8:05 AM

Candel Therapeutics Inc. (NASDAQ: CADL) will host an investor conference call on May 15, 2026, at 1:00 PM ET to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found